6th DVFA Life Sciences Conference

The 6th DVFA Life Science Symposium focuses on innovative R&D and marketing strategies in Pharma, Biotech, Consumer Health, Diagnostics and Medtech. Industry experts will discuss their individual approaches to increased regulatory hurdles, reimbursement challenges, stronger demand for cost-effective therapies and the changing healthcare environment in the wake of Obamacare, Accountable Care Organisations, discount agreements with statutory health insurances and Health Technology Assessment Agencies such as IQWIG and NICE. New strategies and innovative products are needed in all areas of healthcare in order to increase efficiency, effectiveness and quality.

Speakers

• Pharma 2020 – From Vision to Decision
  Dr. Volker Fitzner, Partner, PricewaterhouseCoopers AG Wirtschaftsprüfungsgesellschaft
• Innovative Strategies in R & D to increase efficiency
  Stefan Frings MD, Global Head Medical Affairs Oncology, ROCHE
• Innovative Diagnostics: Case Study QuantiFERON
  Tobias Ruckes, Senior Director Head of Emerging Business & Marketing MDx Europe, QIAGEN N.V.
• Innovative Antibodies
  Dr. Simon Moroney, CEO, MorphoSys AG
• Consumer Health / OTC
  Wolfram Gollin, Leiter Group Management Marketing, STADA Arzneimittel AG
• Innovative Strategies in the Medtech sector
  Prof. Dr. Jörg Vienken, VP BioSciences, Fresenius Medical Care Deutschland GmbH
• Medtech: Getting access to innovations via M&A – from a legal perspective
  Christof Gaudig, Partner, Mayer Brown LLP Rechtsanwälte
• Innovations in Cardiology
  Stephan Wehselau, CFO, JenaValve Technology Inc.

Panel Discussion

• Innovative Strategies in the Pharmaceuticals sector from a capital market perspective
  Moderation: Dr. med. Markus Manns, Union Investment Privatfonds GmbH, Chairman DVFA Commission Life Science
• Innovative Strategies in the Medtech sector from a capital market perspective
  Moderation: Dr. iur. Dr. med. Adem Koyuncu, Partner, Mayer Brown LLP Rechtsanwälte
  

Target group
The symposium is geared to company representatives, sector specialists, investment professionals as well as practicians and representatives from research institutions.

Participation
By invitation only. Participation is free of charge.